Company Overview of ZyStor Therapeutics, Inc.
ZyStor Therapeutics, Inc., a biotechnology company, develops therapeutics for patients with genetic disorders. It offers enzyme replacement therapies for the treatment of lysosomal storage diseases. The company was formerly known as Symbiontics, Inc. ZyStor Therapeutics, Inc. was incorporated in 2004 and is based in Milwaukee, Wisconsin. As of August 17, 2010, ZyStor Therapeutics, Inc. operates as a subsidiary of BioMarin Pharmaceutical Inc.
10437 Innovation Drive
Milwaukee, WI 53226-4838
Founded in 2004
Key Executives for ZyStor Therapeutics, Inc.
Similar Private Companies By Industry
|Paratek Pharmaceuticals, Inc.||United States|
|Silver Creek Pharmaceuticals, Inc.||United States|
|Vitalife, Inc.||United States|
|PNA Innovations, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Germany, PA | Life TechnologiesPosted: Nov 22
- Chicago, IL | Presence HealthPosted: Dec 10
- Billerica, MA | Mergis Group, A Division of SpherionPosted: Dec 10
- Puerto Rico, TX | AbbviePosted: Dec 09
Sponsored Financial Commentaries
To contact ZyStor Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.